Search

Your search keyword '"Dakin, Les A."' showing total 47 results

Search Constraints

Start Over You searched for: Author "Dakin, Les A." Remove constraint Author: "Dakin, Les A."
47 results on '"Dakin, Les A."'

Search Results

1. EZH2 Inhibitor Efficacy in Non-Hodgkin’s Lymphoma Does Not Require Suppression of H3K27 Monomethylation

2. AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia

3. Synthesis of the C1-C11' oxazole-containing side chain of leucascandrolide A. Application of a Sonogashira cross-coupling

4. Heteroarylamide smoothened inhibitors: Discovery of N-[2,4-dimethyl-5-(1-methylimidazol-4-yl)phenyl]-4-(2-pyridylmethoxy)benzamide (AZD8542) and N-[5-(1H-imidazol-2-yl)-2,4-dimethyl-phenyl]-4-(2- pyridylmethoxy)benzamide (AZD7254)

5. Lewis acid-mediated carbocyclization reactions to chiral (E)-crotylsilanes

7. Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas

8. Discovery, design, and synthesis of indole-based EZH2 inhibitors

9. [4+2]-Annulations of chiral organosilanes: Application to the total synthesis of leucascandrolide A

12. Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains

16. Abstract 5526: Inhibition of the histone methyl transferase EZH2 causes viability defects in multiple myeloma

17. A Practical Synthesis of Indoles via a Pd-Catalyzed C–N Ring Formation

20. Structure- and Reactivity-Based Development of Covalent Inhibitors of the Activating and Gatekeeper Mutant Forms of the Epidermal Growth Factor Receptor (EGFR)

21. Abstract 2353: Novel inhibitors of PIM-1, PIM-2, and PIM-3 protein kinases: medicinal chemistry leading to AZD1208.

22. Abstract 4621: The histone methyltransferase EZH2 catalytic activity is required for cell growth in diffuse large B-cell lymphoma.

24. Abstract 2796: Efficacy and biomarker modulation by AZD1208, a novel, potent and selective pan-Pim kinase inhibitor, in models of acute myeloid leukemia

25. AZD1208, a Novel, Potent and Selective Pan PIM Kinase Inhibitor, Demonstrates Efficacy in Models of Acute Myeloid Leukemia

40. Structure-and Reactivity-Based Development of CovalentInhibitors of the Activating and Gatekeeper Mutant Forms of the EpidermalGrowth Factor Receptor (EGFR).

41. [4 + 2]-Annulations of Chiral Organosilanes: Application to the Total Synthesis of Leucascandrolide A.

43. Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.

44. [4 + 2]-annulations of chiral organosilanes: Application to the total synthesis of leucascandrolide A.

45. Enantioselective [4 + 2]-annulation of chiral crotylsilanes: application to the synthesis of a C1-C22 fragment of leucascandrolide A.

46. A mild, chemoselective protocol for the removal of thioketals and thioacetals mediated by Dess-Martin periodinane.

47. Sonogashira coupling of functionalized trifloyl oxazoles and thiazoles with terminal alkynes: synthesis of disubstituted heterocycles.

Catalog

Books, media, physical & digital resources